Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Current Assets (2016 - 2025)

Marimed (MRMD) has disclosed Current Assets for 15 consecutive years, with $60.1 million as the latest value for Q3 2025.

  • On a quarterly basis, Current Assets rose 6.02% to $60.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $60.1 million, a 6.02% increase, with the full-year FY2024 number at $53.5 million, up 4.04% from a year prior.
  • Current Assets was $60.1 million for Q3 2025 at Marimed, up from $57.1 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $60.1 million in Q3 2025 to a low of $31.7 million in Q1 2021.
  • A 5-year average of $50.1 million and a median of $53.1 million in 2024 define the central range for Current Assets.
  • Peak YoY movement for Current Assets: skyrocketed 215.07% in 2021, then fell 17.88% in 2022.
  • Marimed's Current Assets stood at $44.6 million in 2021, then decreased by 1.05% to $44.1 million in 2022, then increased by 16.5% to $51.4 million in 2023, then increased by 4.04% to $53.5 million in 2024, then increased by 12.3% to $60.1 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Current Assets are $60.1 million (Q3 2025), $57.1 million (Q2 2025), and $58.0 million (Q1 2025).